Proteomics of Lung Tissue Reveals Differences in Inflammation and Alveolar-capillary Barrier Response Between Atelectasis and Aerated Regions
Authors
Affiliations
Atelectasis is a frequent clinical condition, yet knowledge is limited and controversial on its biological contribution towards lung injury. We assessed the regional proteomics of atelectatic versus normally-aerated lung tissue to test the hypothesis that immune and alveolar-capillary barrier functions are compromised by purely atelectasis and dysregulated by additional systemic inflammation (lipopolysaccharide, LPS). Without LPS, 130 proteins were differentially abundant in atelectasis versus aerated lung, mostly (n = 126) with less abundance together with negatively enriched processes in immune, endothelial and epithelial function, and Hippo signaling pathway. Instead, LPS-exposed atelectasis produced 174 differentially abundant proteins, mostly (n = 108) increased including acute lung injury marker RAGE and chemokine CCL5. Functional analysis indicated enhanced leukocyte processes and negatively enriched cell-matrix adhesion and cell junction assembly with LPS. Additionally, extracellular matrix organization and TGF-β signaling were negatively enriched in atelectasis with decreased adhesive glycoprotein THBS1 regardless of LPS. Concordance of a subset of transcriptomics and proteomics revealed overlap of leukocyte-related gene-protein pairs and processes. Together, proteomics of exclusively atelectasis indicates decreased immune response, which converts into an increased response with LPS. Alveolar-capillary barrier function-related proteomics response is down-regulated in atelectasis irrespective of LPS. Specific proteomics signatures suggest biological mechanistic and therapeutic targets for atelectasis-associated lung injury.
Clinical significance of postoperative thrombocytosis after vats lobectomy for NSCLC.
Leonardi B, Natale G, Ferraioli S, Leone F, Grande M, Puca M J Cardiothorac Surg. 2024; 19(1):529.
PMID: 39272103 PMC: 11401256. DOI: 10.1186/s13019-024-03032-y.
Prone Positioning and Molecular Biomarkers in COVID and Non-COVID ARDS: A Narrative Review.
Spadaro S, Jimenez-Santana J, La Rosa R, Spinazzola G, Navarro P, Volta C J Clin Med. 2024; 13(2).
PMID: 38256451 PMC: 10816213. DOI: 10.3390/jcm13020317.
Programmed cell death 4 governs NLRP3-mediated pyroptosis in septic lung disorders.
Du W, Ren N, Xu Y, Chen X Mol Biol Rep. 2024; 51(1):77.
PMID: 38183433 DOI: 10.1007/s11033-023-08948-7.
Battaglini D, Al-Husinat L, Normando A, Leme A, Franchini K, Morales M Respir Res. 2022; 23(1):318.
PMID: 36403043 PMC: 9675217. DOI: 10.1186/s12931-022-02233-0.